However, there was no significant impact on the nonspecific killing activity of T cells against MEC1 cells (a CD19-expressing CLL tumor cell line) or on T cell expansion following these procedures (Supplemental Figure 1, E–G). The gene discussed is CD19; the disease is neoplasm.